TJ107

· TJ Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TJ107, covering 2024-04-15 to 2024-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT) [Phase 2]

See pricing